|
|
|
front |1 |2 |3 |4 |5 |6 |7
|8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |review |
 |
You
don‘t need to do any special reading before you look at this
lecture. It is based on an article I wrote
recently:
Cohen CH. Does
the improvement in case ascertainment explain the increase in sporadic
Creutzfeldt-Jakob disease since 1970 in the United Kingdom? Am
J Epidemiol 2000;152:474-9.
<http://www.aje.oupjournals.org/cgi/content/abstract/152/5/474>
If you would like to read more about the issues I discuss, look at:
Clayton D,
Schifflers E. Models for temporal variation in cancer rates. I:
Age-period and age-cohort models. Stat Med 1987;6:449-67.
Cohen CH,
Valleron A-J. When did Bovine Spongiform Encephalopathy start?
Implications on the prediction of a new variant of Creutzfeldt-Jakob
disease (nvCJD) epidemic. Int J Epidemiol 1999;28:526-31.
Cousens S et al.
Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of
epidemiological surveillance data for 1970-96. BMJ 1997;315:389-96.
Neilson S.
Bovine spongiform encephalopathy, Creutzfeldt-Jakob disease and the
remoteness of risk to human populations. BMJ 1996;312:1038-9.
|